Acute‐on‐chronic liver failure in chronic hepatitis B
- 22 March 2012
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 27 (4), 662-669
- https://doi.org/10.1111/j.1440-1746.2011.06971.x
Abstract
Acute‐on‐chronic liver failure (ACLF) in chronic hepatitis B (CHB) is most commonly caused by acute severe exacerbation of CHB. The pathophysiology of ACLF in CHB is still poorly understood. Despite the identification of important predisposing factors and prognostic markers, ACLF in CHB remains a disease associated with high mortality. The majority of studies using nucleoside analog therapy did not show any significant improvement in survival, although larger prospective studies are needed. Liver transplantation is the definitive treatment for ACLF in CHB. The challenge ahead would be prognosticating cases with favorable or unfavorable outcomes in order to streamline patients for early transplantation or for medical therapy.Keywords
This publication has 80 references indexed in Scilit:
- Comparison of effects of hepatitis E or A viral superinfection in patients with chronic hepatitis BHepatology International, 2010
- B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus–associated acute liver failureProceedings of the National Academy of Sciences of the United States of America, 2010
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Epidemiology of Idiosyncratic Drug-Induced Liver InjurySeminars in Liver Disease, 2009
- Liver transplantation for acute-on-chronic liver failureHepatology International, 2009
- Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without RituximabJournal of Clinical Oncology, 2009
- Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)Hepatology International, 2008
- The interleukin-17 pathway is involved in human alcoholic liver diseaseHepatology, 2008
- A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxisHepatology, 2008
- AASLD position paper: The management of acute liver failureHepatology, 2005